+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Asia Pacific Biopharmaceuticals Market Forecast to 2028 -Regional Analysis- Product Image
Asia Pacific Biopharmaceuticals Market Forecast to 2028 -Regional Analysis- Product Image
Sale

Asia Pacific Biopharmaceuticals Market Forecast to 2028 -Regional Analysis

  • PDF Icon

    Report

  • 250 Pages
  • June 2023
  • Region: Asia Pacific
  • The Insight Partners
  • ID: 5887960
UP TO OFF until Dec 31st 2024
Description Jump to:
The Asia Pacific biopharmaceuticals market was valued at US$ 39.96 billion in 2022 and is expected to reach US$ 94.13 billion by 2028. It is estimated to register a CAGR of 15.3% from 2022 to 2028.

Accelerated Clinical Trials to Offer Lucrative Opportunities for Asia Pacific Biopharmaceutical Market

Accelerated progress of clinical trials will ultimately result in the development and commercialization of new drugs targeting rare as well as commonly inherited diseases. Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive, acute leukemia that has been historically difficult to diagnose. In December 2018, Tagraxofusp became the first therapy approved for treating BPDCN, which then became the standard care method. During clinical trials, more than 90% of patients who never received any treatment responded to therapy. Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that weakens muscles, impacts physical function, and causes irreversible brain and spinal cord damage. To date, only 2 products are approved for slowing the functional decline associated with ALS. The accelerated clinical trials for developing new products targeting ALS are in progress. For example, antisense oligonucleotides (ASOs) have been showing promising results in clinical trials involving patients suffering from ALS. Further, different gene therapy approaches, targeting multiple mutations in patients for both sporadic ALS and familial ALS, are in clinical trials. Thus, clinical trials of an extensive pipeline of biopharmaceuticals are expected to offer lucrative growth opportunities to the Asia Pacific biopharmaceuticals market in the coming years.

Asia Pacific Biopharmaceutical Market Overview

The Asia Pacific biopharmaceuticals market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China held the largest share of the market in 2021, and India is expected to exhibit a significant growth in the market. This is due to China's biopharmaceutical industry undergoing a tremendous shift evolving from a generics-focused to a thriving innovation hub. According to the Information Technology & Innovation Foundation (ITIF) report, China has made considerable progress in matching the US in innovation. A decade ago, China was 80% behind the US; however, today, it is just 50% owing to dramatic progress in innovation, technology influx, and favorable state-directed industrial and trade policies.

Asia Pacific Biopharmaceutical Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Biopharmaceutical Market Segmentation

The Asia Pacific biopharmaceutical market is segmented into product type, application, and country.

Based on product type, the Asia Pacific biopharmaceutical market is segmented into monoclonal antibodies, recombinant vaccines, conventional vaccines, recombinant growth factors, purified proteins, recombinant proteins, recombinant hormones, recombinant enzymes, cell & gene therapies, cytokines/interferon/interleukins, and others. In 2022, the monoclonal antibodies segment held the largest share of the Asia Pacific biopharmaceutical market.

The recombinant vaccines segment is further segmented into cancer vaccine, malaria vaccine, ebola vaccine, hepatitis-B vaccine, tetanus vaccine, diphtheria vaccine, cholera vaccine, and others. The conventional vaccines segment is subsegmented into polio vaccine, pox vaccine, and others. The recombinant growth factors segment is further segmented into erythropoietin and granulocyte colony stimulating factor. The purified proteins segment is further divided into leukemia inhibitory factor (LIF), P53 protein, P38 protein, and others. The recombinant proteins segment is further segmented into serum albumin, amyloid protein, defensin, and transferrin. The recombinant hormones segment is further segmented into recombinant human growth hormones, recombinant insulin, and other recombinant hormones. The recombinant enzymes segment is further categorized into enterokinase, cyclase, caspase, and cathepsin. The cell & gene therapies segment is further divided into allogenic products, autologous products, and acellular products.

Based on application, the Asia Pacific biopharmaceutical market is segmented into oncology, inflammatory & infectious disease, autoimmune disorders, metabolic disorders, hormonal disorders & growth failure, cardiovascular diseases, neurological diseases, and others. In 2022, the oncology segment held the largest share of the Asia Pacific biopharmaceutical market.

Based on country, the Asia Pacific biopharmaceutical market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. In 2022, China held the largest share of the Asia Pacific biopharmaceutical market.

AbbVie Inc, AGC Biologics AS, Amgen Inc, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Co, Eli Lilly and Co, Johnson & Johnson, Lonza Group AG, Thermo Fisher Scientific Inc, and WuXi Biologics Inc are among the leading companies operating in the Asia Pacific biopharmaceutical market.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Biopharmaceuticals Market - by Product Type
1.3.2 Asia Pacific Biopharmaceuticals Market - by Application
1.3.3 Asia Pacific Biopharmaceuticals Market - by Country
2. Asia Pacific Biopharmaceuticals Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Biopharmaceuticals Market - Market Landscape
4.1 Overview
4.2 Asia Pacific PEST Analysis
4.3 Expert’s Opinion
5. Asia Pacific Biopharmaceuticals Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Application in Cancer Therapeutics
5.1.2 Potential to Treat Rare Diseases
5.2 Market Restraints
5.2.1 High Cost of Manufacturing Infrastructure
5.3 Market Opportunities
5.3.1 Accelerated Clinical Trials
5.4 Future Trends
5.4.1 Contract Manufacturing of Biopharmaceuticals
5.5 Impact Analysis
6. Biopharmaceuticals Market - Asia Pacific Analysis
6.1 Asia Pacific Biopharmaceuticals Market Revenue Forecast and Analysis
7. Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 - by Product Type
7.1 Overview
7.2 Asia Pacific Biopharmaceuticals Market Revenue Share, by Product Type 2021 & 2028 (%)
7.3 Monoclonal Antibodies
7.3.1 Overview
7.3.2 Monoclonal Antibodies: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Recombinant Vaccines
7.4.1 Overview
7.4.2 Recombinant Vaccines: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.4.2.1 Cancer Vaccine
7.4.2.1.1 Overview
7.4.2.1.2 Cancer Vaccine: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.4.2.2 Malaria Vaccine
7.4.2.2.1 Overview
7.4.2.2.2 Malaria Vaccine: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.4.2.3 Ebola Vaccine
7.4.2.3.1 Overview
7.4.2.3.2 Ebola Vaccine: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.4.2.4 Hepatitis-B Vaccine
7.4.2.4.1 Overview
7.4.2.4.2 Hepatitis-B Vaccine: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.4.2.5 Tetanus Vaccine
7.4.2.5.1 Overview
7.4.2.5.2 Tetanus Vaccine: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.4.2.6 Diphtheria Vaccine
7.4.2.6.1 Overview
7.4.2.6.2 Diphtheria Vaccine: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.4.2.7 Cholera Vaccine
7.4.2.7.1 Overview
7.4.2.7.2 Cholera Vaccine: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.4.2.8 Others
7.4.2.8.1 Overview
7.4.2.8.2 Others: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Conventional Vaccines
7.5.1 Overview
7.5.2 Conventional Vaccines: Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.5.2.1 Polio Vaccine
7.5.2.1.1 Overview
7.5.2.1.2 Polio Vaccine: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.5.2.2 Pox Vaccine
7.5.2.2.1 Overview
7.5.2.2.2 Pox Vaccine: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.5.2.3 Other Conventional Vaccine
7.5.2.3.1 Overview
7.5.2.3.2 Other Conventional Vaccine: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Recombinant Growth Factors
7.6.1 Overview
7.6.2 Recombinant Growth Factors: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.6.2.1 Erythropoietin
7.6.2.1.1 Overview
7.6.2.1.2 Erythropoietin: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.6.2.2 Granulocyte Colony Stimulating Factor
7.6.2.2.1 Overview
7.6.2.2.2 Granulocyte Colony Stimulating Factor: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.7 Purified Proteins
7.7.1 Overview
7.7.2 Purified Proteins: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.7.2.1 Leukemia Inhibitory Factor (LIF)
7.7.2.1.1 Overview
7.7.2.1.2 Leukemia Inhibitory Factor (LIF): Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.7.2.2 P53 Protein
7.7.2.2.1 Overview
7.7.2.2.2 P53 Protein: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.7.2.3 P38 Protein
7.7.2.3.1 Overview
7.7.2.3.2 P38 Protein: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.7.2.4 Other Purified Proteins
7.7.2.4.1 Overview
7.7.2.4.2 Other Purified Proteins: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.8 Recombinant Proteins
7.8.1 Overview
7.8.2 Recombinant Proteins: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.8.2.1 Serum Albumin
7.8.2.1.1 Overview
7.8.2.1.2 Serum Albumin: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.8.2.2 Amyloid Protein
7.8.2.2.1 Overview
7.8.2.2.2 Amyloid Protein: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.8.2.3 Defensin
7.8.2.3.1 Overview
7.8.2.3.2 Defensin: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.8.2.4 Transferrin
7.8.2.4.1 Overview
7.8.2.4.2 Transferrin: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.9 Recombinant Hormones
7.9.1 Overview
7.9.2 Recombinant Hormones: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.9.2.1 Recombinant Human Growth Hormones
7.9.2.1.1 Overview
7.9.2.1.2 Recombinant Human Growth Hormones: Asia pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.9.2.2 Recombinant Insulin
7.9.2.2.1 Overview
7.9.2.2.2 Recombinant Insulin: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.9.2.3 Other Recombinant Hormones
7.9.2.3.1 Overview
7.9.2.3.2 Other Recombinant Hormones: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.10 Recombinant Enzymes
7.10.1 Overview
7.10.2 Recombinant Enzymes: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.10.2.1 Enterokinase
7.10.2.1.1 Overview
7.10.2.1.2 Enterokinase: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.10.2.2 Cyclase
7.10.2.2.1 Overview
7.10.2.2.2 Cyclase: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.10.2.3 Caspase
7.10.2.3.1 Overview
7.10.2.3.2 Caspase: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.10.2.4 Cathepsin
7.10.2.4.1 Overview
7.10.2.4.2 Cathepsin: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.11 Cell and Gene Therapies
7.11.1 Overview
7.11.2 Cell and Gene Therapies: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.11.2.1 Allogenic Products
7.11.2.1.1 Overview
7.11.2.1.2 Allogenic Products: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.11.2.2 Autologous Products
7.11.2.2.1 Overview
7.11.2.2.2 Autologous Products: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.11.2.3 Acellular Products
7.11.2.3.1 Overview
7.11.2.3.2 Acellular Products: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.12 Cytokines/Interferon/Interleukins
7.12.1 Overview
7.12.2 Cytokines/Interferon/Interleukins: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.13 Others (mRNA Based Therapeutics, etc.)
7.13.1 Overview
7.13.2 Others (mRNA Based Therapeutics, etc.): Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
8. Asia Pacific Biopharmaceuticals Market Analysis and Forecasts to 2028 - by Application
8.1 Overview
8.2 Asia Pacific Biopharmaceuticals Market, by Application 2021 & 2028 (%)
8.3 Oncology
8.3.1 Overview
8.3.2 Oncology: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Inflammatory and Infectious Diseases
8.4.1 Overview
8.4.2 Inflammatory and Infectious Diseases: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Autoimmune Disorders
8.5.1 Overview
8.5.2 Autoimmune Disorders: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Metabolic Disorders
8.6.1 Overview
8.6.2 Metabolic Disorders: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
8.7 Hormonal Disorders and Growth Failure
8.7.1 Overview
8.7.2 Hormonal Disorders and Growth Failure: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
8.8 Cardiovascular Diseases
8.8.1 Overview
8.8.2 Cardiovascular Diseases: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
8.9 Neurological Diseases
8.9.1 Overview
8.9.2 Neurological Diseases: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
8.10 Other Therapeutic Applications
8.10.1 Overview
8.10.2 Other Therapeutic Applications: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
9. Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 - Country Analysis
9.1 Overview
9.1.1 Asia Pacific: Biopharmaceuticals Market, by Country, 2021 & 2028 (%)
9.1.1.1 China: Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.1.1 China: Biopharmaceuticals Market, by Product Type, 2019-2028 (US$ Million)
9.1.1.1.1.1 China: Biopharmaceuticals Market, by Recombinant Vaccines, 2019-2028 (US$ Million)
9.1.1.1.1.2 China: Biopharmaceuticals Market, by Conventional Vaccines, 2019-2028 (US$ Million)
9.1.1.1.1.3 China: Biopharmaceuticals Market, by Recombinant Growth Factors, 2019-2028 (US$ Million)
9.1.1.1.1.4 China: Biopharmaceuticals Market, by Purified Proteins, 2019-2028 (US$ Million)
9.1.1.1.1.5 China: Biopharmaceuticals Market, by Recombinant Proteins, 2019-2028 (US$ Million)
9.1.1.1.1.6 China: Biopharmaceuticals Market, by Recombinant Hormones, 2019-2028 (US$ Million)
9.1.1.1.1.7 China: Biopharmaceuticals Market, by Recombinant Enzymes, 2019-2028 (US$ Million)
9.1.1.1.1.8 China: Biopharmaceuticals Market, by Cell & Gene Therapies, 2019-2028 (US$ Million)
9.1.1.1.2 China: Biopharmaceuticals Market, by Application, 2019-2028 (US$ Million)
9.1.1.2 Japan: Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.2.1 Japan: Biopharmaceuticals Market, by Product Type, 2019-2028 (US$ Million)
9.1.1.2.1.1 Japan: Biopharmaceuticals Market, by Recombinant Vaccines, 2019-2028 (US$ Million)
9.1.1.2.1.2 Japan: Biopharmaceuticals Market, by Conventional Vaccines, 2019-2028 (US$ Million)
9.1.1.2.1.3 Japan: Biopharmaceuticals Market, by Recombinant Growth Factors, 2019-2028 (US$ Million)
9.1.1.2.1.4 Japan: Biopharmaceuticals Market, by Purified Proteins, 2019-2028 (US$ Million)
9.1.1.2.1.5 Japan: Biopharmaceuticals Market, by Recombinant Proteins, 2019-2028 (US$ Million)
9.1.1.2.1.6 Japan: Biopharmaceuticals Market, by Recombinant Hormones, 2019-2028 (US$ Million)
9.1.1.2.1.7 Japan: Biopharmaceuticals Market, by Recombinant Enzymes, 2019-2028 (US$ Million)
9.1.1.2.1.8 Japan: Biopharmaceuticals Market, by Cell & Gene Therapies, 2019-2028 (US$ Million)
9.1.1.2.2 Japan: Biopharmaceuticals Market, by Application, 2019-2028 (US$ Million)
9.1.1.3 India: Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.3.1 India: Biopharmaceuticals Market, by Product Type, 2019-2028 (US$ Million)
9.1.1.3.1.1 India: Biopharmaceuticals Market, by Recombinant Vaccines, 2019-2028 (US$ Million)
9.1.1.3.1.2 India: Biopharmaceuticals Market, by Conventional Vaccines, 2019-2028 (US$ Million)
9.1.1.3.1.3 India: Biopharmaceuticals Market, by Recombinant Growth Factors, 2019-2028 (US$ Million)
9.1.1.3.1.4 India: Biopharmaceuticals Market, by Purified Proteins, 2019-2028 (US$ Million)
9.1.1.3.1.5 India: Biopharmaceuticals Market, by Recombinant Proteins, 2019-2028 (US$ Million)
9.1.1.3.1.6 India: Biopharmaceuticals Market, by Recombinant Hormones, 2019-2028 (US$ Million)
9.1.1.3.1.7 India: Biopharmaceuticals Market, by Recombinant Enzymes, 2019-2028 (US$ Million)
9.1.1.3.1.8 India: Biopharmaceuticals Market, by Cell & Gene Therapies, 2019-2028 (US$ Million)
9.1.1.3.2 India: Biopharmaceuticals Market, by Application, 2019-2028 (US$ Million)
9.1.1.4 South Korea: Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.4.1 South Korea: Biopharmaceuticals Market, by Product Type, 2019-2028 (US$ Million)
9.1.1.4.1.1 South Korea: Biopharmaceuticals Market, by Recombinant Vaccines, 2019-2028 (US$ Million)
9.1.1.4.1.2 South Korea: Biopharmaceuticals Market, by Conventional Vaccines, 2019-2028 (US$ Million)
9.1.1.4.1.3 South Korea: Biopharmaceuticals Market, by Recombinant Growth Factors, 2019-2028 (US$ Million)
9.1.1.4.1.4 South Korea: Biopharmaceuticals Market, by Purified Proteins, 2019-2028 (US$ Million)
9.1.1.4.1.5 South Korea: Biopharmaceuticals Market, by Recombinant Proteins, 2019-2028 (US$ Million)
9.1.1.4.1.6 South Korea: Biopharmaceuticals Market, by Recombinant Hormones, 2019-2028 (US$ Million)
9.1.1.4.1.7 South Korea: Biopharmaceuticals Market, by Recombinant Enzymes, 2019-2028 (US$ Million)
9.1.1.4.1.8 South Korea: Biopharmaceuticals Market, by Cell & Gene Therapies, 2019-2028 (US$ Million)
9.1.1.4.2 South Korea: Biopharmaceuticals Market, by Application, 2019-2028 (US$ Million)
9.1.1.5 Australia: Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.5.1 Australia: Biopharmaceuticals Market, by Product Type, 2019-2028 (US$ Million)
9.1.1.5.1.1 Australia: Biopharmaceuticals Market, by Recombinant Vaccines, 2019-2028 (US$ Million)
9.1.1.5.1.2 Australia: Biopharmaceuticals Market, by Conventional Vaccines, 2019-2028 (US$ Million)
9.1.1.5.1.3 Australia: Biopharmaceuticals Market, by Recombinant Growth Factors, 2019-2028 (US$ Million)
9.1.1.5.1.4 Australia: Biopharmaceuticals Market, by Purified Proteins, 2019-2028 (US$ Million)
9.1.1.5.1.5 Australia: Biopharmaceuticals Market, by Recombinant Proteins, 2019-2028 (US$ Million)
9.1.1.5.1.6 Australia: Biopharmaceuticals Market, by Recombinant Hormones, 2019-2028 (US$ Million)
9.1.1.5.1.7 Australia: Biopharmaceuticals Market, by Recombinant Enzymes, 2019-2028 (US$ Million)
9.1.1.5.1.8 Australia: Biopharmaceuticals Market, by Cell & Gene Therapies, 2019-2028 (US$ Million)
9.1.1.5.2 Australia: Biopharmaceuticals Market, by Application, 2019-2028 (US$ Million)
9.1.1.6 Rest of Asia Pacific: Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.6.1 Rest of Asia Pacific: Biopharmaceuticals Market, by Product Type, 2019-2028 (US$ Million)
9.1.1.6.1.1 Rest of Asia Pacific: Biopharmaceuticals Market, by Recombinant Vaccines, 2019-2028 (US$ Million)
9.1.1.6.1.2 Rest of Asia Pacific: Biopharmaceuticals Market, by Conventional Vaccines, 2019-2028 (US$ Million)
9.1.1.6.1.3 Rest of Asia Pacific: Biopharmaceuticals Market, by Recombinant Growth Factors, 2019-2028 (US$ Million)
9.1.1.6.1.4 Rest of Asia Pacific: Biopharmaceuticals Market, by Purified Proteins, 2019-2028 (US$ Million)
9.1.1.6.1.5 Rest of Asia Pacific: Biopharmaceuticals Market, by Recombinant Proteins, 2019-2028 (US$ Million)
9.1.1.6.1.6 Rest of Asia Pacific: Biopharmaceuticals Market, by Recombinant Hormones, 2019-2028 (US$ Million)
9.1.1.6.1.7 Rest of Asia Pacific: Biopharmaceuticals Market, by Recombinant Enzymes, 2019-2028 (US$ Million)
9.1.1.6.1.8 Rest of Asia Pacific: Biopharmaceuticals Market, by Cell & Gene Therapies, 2019-2028 (US$ Million)
9.1.1.6.2 Rest of Asia Pacific: Biopharmaceuticals Market, by Application, 2019-2028 (US$ Million)
10. Asia Pacific Biopharmaceuticals Market - Industry Landscape
10.1 Overview
10.2 Organic Growth Strategies
10.2.1 Overview
10.3 Inorganic Growth Strategies
10.3.1 Overview
11. Company Profiles
11.1 Amgen Inc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 AbbVie Inc
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Eli Lilly and Co
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Bristol-Myers Squibb Co
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Johnson & Johnson
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Boehringer Ingelheim International GmbH
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Thermo Fisher Scientific Inc
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 AGC Biologics AS
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Lonza Group AG
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 WuXi Biologics Inc
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About The Publisher
12.2 Glossary of Terms
List of Tables
Table 1. Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Table 2. China Biopharmaceuticals Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 3. China Biopharmaceuticals Market, by Recombinant Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 4. China Biopharmaceuticals Market, by Conventional Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 5. China Biopharmaceuticals Market, by Recombinant Growth Factors - Revenue and Forecast to 2028 (US$ Million)
Table 6. China Biopharmaceuticals Market, by Purified Proteins - Revenue and Forecast to 2028 (US$ Million)
Table 7. China Biopharmaceuticals Market, by Recombinant Proteins - Revenue and Forecast to 2028 (US$ Million)
Table 8. China Biopharmaceuticals Market, by Recombinant Hormones - Revenue and Forecast to 2028 (US$ Million)
Table 9. China Biopharmaceuticals Market, by Recombinant Enzymes - Revenue and Forecast to 2028 (US$ Million)
Table 10. China Biopharmaceuticals Market, by Cell & Gene Therapies - Revenue and Forecast to 2028 (US$ Million)
Table 11. China Biopharmaceuticals Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 12. Japan Biopharmaceuticals Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 13. Japan Biopharmaceuticals Market, by Recombinant Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 14. Japan Biopharmaceuticals Market, by Conventional Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 15. Japan Biopharmaceuticals Market, by Recombinant Growth Factors - Revenue and Forecast to 2028 (US$ Million)
Table 16. Japan Biopharmaceuticals Market, by Purified Proteins - Revenue and Forecast to 2028 (US$ Million)
Table 17. Japan Biopharmaceuticals Market, by Recombinant Proteins - Revenue and Forecast to 2028 (US$ Million)
Table 18. Japan Biopharmaceuticals Market, by Recombinant Hormones - Revenue and Forecast to 2028 (US$ Million)
Table 19. Japan Biopharmaceuticals Market, by Recombinant Enzymes - Revenue and Forecast to 2028 (US$ Million)
Table 20. Japan Biopharmaceuticals Market, by Cell & Gene Therapies - Revenue and Forecast to 2028 (US$ Million)
Table 21. Japan Biopharmaceuticals Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 22. India Biopharmaceuticals Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 23. India Biopharmaceuticals Market, by Recombinant Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 24. India Biopharmaceuticals Market, by Conventional Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 25. India Biopharmaceuticals Market, by Recombinant Growth Factors - Revenue and Forecast to 2028 (US$ Million)
Table 26. India Biopharmaceuticals Market, by Purified Proteins - Revenue and Forecast to 2028 (US$ Million)
Table 27. India Biopharmaceuticals Market, by Recombinant Proteins - Revenue and Forecast to 2028 (US$ Million)
Table 28. India Biopharmaceuticals Market, by Recombinant Hormones - Revenue and Forecast to 2028 (US$ Million)
Table 29. India Biopharmaceuticals Market, by Recombinant Enzymes - Revenue and Forecast to 2028 (US$ Million)
Table 30. India Biopharmaceuticals Market, by Cell & Gene Therapies - Revenue and Forecast to 2028 (US$ Million)
Table 31. India Biopharmaceuticals Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 32. South Korea Biopharmaceuticals Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 33. South Korea Biopharmaceuticals Market, by Recombinant Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 34. South Korea Biopharmaceuticals Market, by Conventional Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 35. South Korea Biopharmaceuticals Market, by Recombinant Growth Factors - Revenue and Forecast to 2028 (US$ Million)
Table 36. South Korea Biopharmaceuticals Market, by Purified Proteins - Revenue and Forecast to 2028 (US$ Million)
Table 37. South Korea Biopharmaceuticals Market, by Recombinant Proteins - Revenue and Forecast to 2028 (US$ Million)
Table 38. South Korea Biopharmaceuticals Market, by Recombinant Hormones - Revenue and Forecast to 2028 (US$ Million)
Table 39. South Korea Biopharmaceuticals Market, by Recombinant Enzymes - Revenue and Forecast to 2028 (US$ Million)
Table 40. South Korea Biopharmaceuticals Market, by Cell & Gene Therapies - Revenue and Forecast to 2028 (US$ Million)
Table 41. South Korea Biopharmaceuticals Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 42. Australia Biopharmaceuticals Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 43. Australia Biopharmaceuticals Market, by Recombinant Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 44. Australia Biopharmaceuticals Market, by Conventional Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 45. Australia Biopharmaceuticals Market, by Recombinant Growth Factors - Revenue and Forecast to 2028 (US$ Million)
Table 46. Australia Biopharmaceuticals Market, by Purified Proteins - Revenue and Forecast to 2028 (US$ Million)
Table 47. Australia Biopharmaceuticals Market, by Recombinant Proteins - Revenue and Forecast to 2028 (US$ Million)
Table 48. Australia Biopharmaceuticals Market, by Recombinant Hormones - Revenue and Forecast to 2028 (US$ Million)
Table 49. Australia Biopharmaceuticals Market, by Recombinant Enzymes - Revenue and Forecast to 2028 (US$ Million)
Table 50. Australia Biopharmaceuticals Market, by Cell & Gene Therapies - Revenue and Forecast to 2028 (US$ Million)
Table 51. Australia Biopharmaceuticals Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 52. Rest of Asia Pacific Biopharmaceuticals Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 53. Rest of Asia Pacific Biopharmaceuticals Market, by Recombinant Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 54. Rest of Asia Pacific Biopharmaceuticals Market, by Conventional Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 55. Rest of Asia Pacific Biopharmaceuticals Market, by Recombinant Growth Factors - Revenue and Forecast to 2028 (US$ Million)
Table 56. Rest of Asia Pacific Biopharmaceuticals Market, by Purified Proteins - Revenue and Forecast to 2028 (US$ Million)
Table 57. Rest of Asia Pacific Biopharmaceuticals Market, by Recombinant Proteins - Revenue and Forecast to 2028 (US$ Million)
Table 58. Rest of Asia Pacific Biopharmaceuticals Market, by Recombinant Hormones - Revenue and Forecast to 2028 (US$ Million)
Table 59. Rest of Asia Pacific Biopharmaceuticals Market, by Recombinant Enzymes - Revenue and Forecast to 2028 (US$ Million)
Table 60. Rest of Asia Pacific Biopharmaceuticals Market, by Cell & Gene Therapies - Revenue and Forecast to 2028 (US$ Million)
Table 61. Rest of Asia Pacific Biopharmaceuticals Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 62. Recent Organic Growth Strategies in Biopharmaceuticals Market
Table 63. Recent Inorganic Growth Strategies in the Asia Pacific biopharmaceuticals market
Table 64. Glossary of Terms
List of Figure
Figure 1. Asia Pacific Biopharmaceuticals Market Segmentation
Figure 2. Asia Pacific Biopharmaceuticals Market, by Country
Figure 3. Asia Pacific Biopharmaceuticals Market Overview
Figure 4. Monoclonal Antibodies Segment Held Largest Share of Product Type Segment in Asia Pacific Biopharmaceuticals Market
Figure 5. China Expected to Show Remarkable Growth During Forecast Period
Figure 6. Asia Pacific: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. Asia Pacific Biopharmaceuticals Market: Impact Analysis of Drivers and Restraints
Figure 9. Asia Pacific Biopharmaceuticals Market - Revenue Forecast and Analysis - 2020-2028
Figure 10. Asia Pacific Biopharmaceuticals Market Revenue Share, by Product Type 2021 & 2028 (%)
Figure 11. Monoclonal Antibodies: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Recombinant Vaccines: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Cancer Vaccine: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. Malaria Vaccine: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 15. Ebola Vaccine: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. Hepatitis-B Vaccine: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. Tetanus Vaccine: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Diphtheria Vaccine: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. Cholera Vaccine: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Others: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Conventional Vaccines: Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Polio Vaccine: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Pox Vaccine: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Other Conventional Vaccine: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Recombinant Growth Factors: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Erythropoietin: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Granulocyte Colony Stimulating Factor: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Purified Proteins: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. Leukemia Inhibitory Factor (LIF): Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. P53 Protein: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. P38 Protein: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 32. Other Purified Proteins: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. Recombinant Proteins: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 34. Serum Albumin: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 35. Amyloid Protein: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 36. Defensin: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 37. Transferrin: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 38. Recombinant Hormones: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 39. Recombinant Human Growth Hormones: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 40. Recombinant Insulin: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 41. Other Recombinant Hormones: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 42. Recombinant Enzymes: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 43. Enterokinase: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 44. Cyclase: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 45. Caspase: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 46. Cathepsin: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 47. Cell and Gene Therapies: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 48. Allogenic Products: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 49. Autologous Products: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 50. Acellular Products: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 51. Cytokines/Interferon/Interleukins: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 52. Others (mRNA Based Therapeutics, etc.): Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 53. Asia Pacific Biopharmaceuticals Market, by Application 2021 & 2028 (%)
Figure 54. Oncology: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 55. Inflammatory and Infectious Diseases: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 56. Autoimmune Disorders: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 57. Metabolic Disorders: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 58. Hormonal Disorders and Growth Failure: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 59. Cardiovascular Diseases: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 60. Neurological Diseases: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 61. Other Therapeutic Applications: Asia Pacific Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 62. Asia Pacific: Biopharmaceuticals Market, by Key Country - Revenue (2021) (US$ Million)
Figure 63. China: Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 64. Japan: Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 65. India: Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 66. South Korea: Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 67. Australia: Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
Figure 68. Rest of Asia Pacific: Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)

Companies Mentioned

  • AbbVie Inc
  • AGC Biologics AS
  • Amgen Inc
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Co
  • Eli Lilly and Co
  • Johnson & Johnson
  • Lonza Group AG
  • Thermo Fisher Scientific Inc
  • WuXi Biologics Inc

Table Information

Report AttributeDetails
No. of Pages250
PublishedJune 2023
Forecast Period2022 - 2028
Estimated Market Value ( USD ) in 2022 $ 39.96 billion
Forecasted Market Value ( USD ) by 2028 $ 94.13 billion
Compound Annual Growth Rate15.3%
Regions CoveredAsia Pacific
No. of Companies Mentioned10

Related Topics

Related Reports

Biopharmaceuticals Market by Product Type, Services, Raw Material Type, Application - Global Forecast 2025-2030 - Product Image

Biopharmaceuticals Market by Product Type, Services, Raw Material Type, Application - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
North America Biopharmaceuticals Market Forecast to 2028 -Regional Analysis - Product Image

North America Biopharmaceuticals Market Forecast to 2028 -Regional Analysis

  • Report
  • 224 Pages
  • North America
From
Europe Biopharmaceuticals Market Forecast to 2028 -Regional Analysis - Product Image

Europe Biopharmaceuticals Market Forecast to 2028 -Regional Analysis

  • Report
  • 253 Pages
  • Europe
From
Biopharmaceutical Tubing Market Report 2024 - Product Image

Biopharmaceutical Tubing Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Biopharmaceuticals - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Biopharmaceuticals - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From

About the Biopharmaceuticals Market

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders. Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively. Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.